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Inflammasomes are critical sensors that convey cellular stress and
pathogen presence to the immune system by activating inflamma-
tory caspases and cytokines such as IL-1β. The nature of endogenous
stress signals that activate inflammasomes remains unclear. Here
we show that an inhibitor of the HIV aspartyl protease, Nelfinavir,
triggers inflammasome formation and elicits an IL-1R–dependent
inflammation in mice. We found that Nelfinavir impaired the matu-
ration of lamin A, a structural component of the nuclear envelope,
thereby promoting the release of DNA in the cytosol. Moreover,
deficiency of the cytosolic DNA-sensor AIM2 impaired Nelfinavir-
mediated inflammasome activation. These findings identify a phar-
macologic activator of inflammasome and demonstrate the role of
AIM2 in detecting endogenous DNA release upon perturbation of
nuclear envelope integrity.
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Pattern-recognition receptors detect microbial componentsand danger signals released by damaged tissues to trigger in-
flammatory responses. Among these, members of the nucleotide-
binding and oligomerization domain (NOD)-like receptors (NLRs)
and AIM2-like receptors can assemble into enzymatically active
complexes known as the inflammasomes (1). These complexes
coordinate the recruitment and activation of inflammatory caspases
to regulate the processing and release of bioactive cytokines in-
cluding IL-1β or IL-18 (2, 3). This pathway contributes to immune
responses to pathogens, and its deregulation has been associated
with inflammation in autoinflammatory syndromes as well as in
complex diseases such as metabolic disorders and cancer (4, 5). In
recent years tremendous progress has revealed several mechanisms
involved in the activation of inflammasome (6).
Some inflammasome sensors have been shown to directly bind
and recognize pathogen signatures. For example, the cytosolic
release of microbial double-stranded DNA is detected by the
C-terminal DNA-binding region of the protein AIM2. This leads
to AIM2 oligomerization and the recruitment of the adaptor ASC
and the protease caspase-1 to the forming inflammasome (7–10).
Other inflammasomes have been shown to detect intrinsic cellular
perturbations. Potassium efflux, mitochondria dysfunction, and ly-
sosomal disruption have been reported to mediate the activation of
NLRP3, leading to the hypothesis that this inflammasome is a
guardian of cellular integrity (11, 12). In addition to detecting mi-
tochondrial perturbations, NLRP3 was found to be activated by
endoplasmic reticulum (ER) stress in different tissues including
macrophages (13, 14), liver (15), and insulin-producing β cells (16,
17). Inflammasome activation may therefore contribute to the low-
grade inflammation (parainflammation) that characterizes stressed
or malfunctioning cells, hence promoting adaptation and restora-
tion of tissue function (18).
The HIV-protease inhibitors (HIV-PIs), in particular Nelfinavir
(NFR), have been proposed to induce cellular stress both in vivo
and in vitro (19, 20). Beyond their broad use as anti-HIV drugs,
these molecules display beneficial HIV-unrelated functions, anti-
malaria, antituberculosis, and antitumor properties (20). At the
cellular level, the HIV-PIs trigger an atypical ER stress-like
transcriptional response that relies mostly on the activation of the
integrated stress response (19, 21). However, the exact nature of
the stress response engaged by these drugs is poorly understood, and
its possible contribution to inflammation has not been investigated.
In brief, here we studied the stress response engaged by Nelfi-
navir and report that this molecule triggers robust inflammasome
activation. Mechanistically, we found that Nelfinavir impaired the
maturation of lamin A, a structural component of the nuclear
envelope, thereby triggering a specific perturbation of cellular
homeostasis here defined as “nuclear envelope stress.” We show
that alterations of nuclear envelope integrity promote the release
of DNA in the cytosol and consequent AIM2 activation. These
findings demonstrate a function for AIM2 inflammasome in mon-
itoring nuclear integrity by promoting activation of inflammatory
caspases if cytosolic release of self-DNA is detected.
Results
The Antiviral Drug Nelfinavir Triggers the Release of IL-1β to Promote
Inflammation. Nelfinavir has been widely used in HIV-infected
patients. Drug concentration can reach up to 17 μM in the plasma
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of treated patients (22, 23). We recently showed that concentra-
tions can reach 10 μM in liver tissues of mice treated with an i.p.
dose of NFR reproducing the plasma concentration measured in
patients (19). We used the same protocol to interrogate NFR-
mediated inflammation in mice. Five hours after i.p. injection,
NFR triggered the release of IL-1β in the peritoneal lavage of
treated mice (Fig. 1A). Consistent with these observations, NFR
mediated a neutrophil influx that was impaired in IL-1R–deficient
mice compared with control animals (Fig. 1B). These data indicate
that NFR can mediate an IL-1–dependent peritonitis in mice
similarly to well-known inflammasome activators (24). IL-1β re-
lease by NFR was also observed in mouse bone marrow-derived
macrophages (BMDMs) and differentiated THP-1 cells treated
with NFR (Fig. 1 C and D), indicating that NFR-mediated stress
response may promote inflammation by directly inducing IL-1β
maturation and release.
Treatment with Nelfinavir Activates Caspase-1. Caspase-1 is the
best-characterized protease triggering rapid proIL-1β processing
and maturation. To interrogate caspase-1 activation, we moni-
tored its processing and release in the supernatant of immortal-
ized BMDMs (iBMDMs). Upon treatment with NFR, caspase-1
processing was observed and correlated with released IL-1β (Fig. 2
A and B), suggesting that this protease may direct IL-1β matura-
tion in the context of NFR-mediated stress response. Investigation
of a panel of HIV-protease inhibitors used in the clinic revealed
that most members of the family triggered some IL-1β maturation
and caspase-1 activation (Fig. S1A). However, we consistently
found that, among these molecules, NFR is the most robust in-
ducer of this pathway at relevant concentrations. In contrast, other
anti-HIV drugs such as the nonnucleoside reverse transcriptase
inhibitor Efavirenz did not trigger significant release of active IL-1β
(Fig. S1B).
Treatment of BMDMs with the pan-caspase inhibitor zVAD-
FMK impaired NFR-mediated IL-1β release (Fig. 2C). Similarly,
caspase-1 and -11 deficiency dampened NFR-mediated IL-1β
release (Fig. 2D and Fig. S1C). Inflammatory caspase activation
triggers pyroptosis, a type of cell death that correlates with the
release of cytosolic content including cytokines and danger signals
(25). We measured pyroptosis by monitoring LDH release and
observed that NFR triggered a caspase-1/11–dependent form of
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Fig. 1. NFR triggers the release of active IL-1β. (A and B) Mice received in-
traperitoneally 0.2 mL of vehicle alone or supplemented with 100 mg/kg of
NFR. Lavages were harvested after 5 h and analyzed for IL-1β by ELISA (A). IL-
1R+/+ (WT) and IL-1R−/− were analyzed for neutrophil influx (CD11b+, LY6C+,
LY6G+) by FACS (B). Data are pooled from two independent experiments
and shown as means ± SEM *P < 0.05; **P < 0.01 (six to eight mice per group
were analyzed). (C) LPS-primed BMDMs were treated with MSU (positive
control) and NFR as indicated. IL-1β was monitored by ELISA at 6 h of
treatment. Data are representative of at least three independent experi-
ments. (D) PMA-differentiated THP-1 cells were stimulated with NFR for 6 h,
and IL-1β release was tested by ELISA. Data are representative of three in-
dependent experiments.
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Fig. 2. Inflammatory caspases are required for IL-1β release and pyroptosis
upon treatment with NFR. (A–C) iBMDMs were primed with LPS and treated
with 5 μM NG for 1 h or NFR for 6 h at the indicated concentrations. Caspase-
1 expression and maturation was probed by immunoblot in supernatant (SN)
or cell extracts (XT) (A); released IL-1β was measured by ELISA (B). The role of
caspases was interrogated upon incubation with 20 μM NFR in the presence
or absence of zVAD-fmk (C). Data are representative of at least three in-
dependent experiments. (D) Released IL-1β was measured by ELISA in LPS-
primed caspase-1/11–deficient BMDMs or control cells (WT) treated for 6 h
with Lipofectamine (Lipo), Lipo in combination with 1 μg/mL poly(dA:dT)
[Poly(dA:dT)], or NFR as indicated. Data are representative of three in-
dependent experiments. (E) LDH release from LPS-primed caspase-1/11–
deficient BMDMs or control cells (WT) treated for 1 h with 5 μM NG or 6 h
with 50 μg/mL MSU, 1 μg/mL poly(dA:dT), or NFR as indicated. Data are
representative of two independent experiments.
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Fig. 3. NFR triggers the assembly of an ASC-dependent inflammasome. (A) BMDMs were primed with LPS and treated with NFR, poly(dA:dT), or NG as
indicated. Cross-linked pellets (Pell) or soluble lysates (Lys) were immunoblotted for ASC or caspase-1. Data are representative of three independent ex-
periments. (B) Immunofluorescence microscopy of BMDMs primed with LPS and treated with Lipo, Lipo in combination with 1 μg/mL poly(dA:dT) [Poly(dA:
dT)], or NFR as indicated. DNA staining is shown in blue (Hoechst); ASC staining is shown in green. Arrowheads indicate ASC inflammasome specks. (Scale bar:
10 μm.) (C) ImageStream flow cytometric analysis of ASC inflammasomes. (Left) Representative images of LPS-primed BMDMs treated with vehicle (Mock) or
NFR and stained with Hoechst in blue (DNA), lamin B1 in green (nucleus), and ASC in red. (Right) Quantification of ASC specks detected at 6 h upon treatment
with poly(dA:dT) or NFR. Data are means ± SEM from three independent experiments analyzing at least 20,000 cells. *P < 0.05; ***P < 0.001. (D) Human THP-1
macrophages expressing a scrambled shRNA (shScrbl) or an shRNA directed against ASC (shASC) were differentiated and primed with PMA (0.5 μM) and
treated with 5 μM NG for 30 min or NFR for 6 h as indicated. (Left) Immunoblot of cleaved IL-1β released in the supernatant (SN). Cell extracts were analyzed
for ASC, caspase-1, and pro–IL-1β expression. (Right) Secreted IL-1β was measured by ELISA. (E) Immunoblot analysis of caspase-1 and IL-1βmaturation in ASC-
deficient and control (WT) BMDMs primed with LPS as indicated and treated with NG, MSU, Lipo, poly(dA:dT), and NFR. SN: supernatants; XT: cell extracts.
Tubulin was used as a loading control. Data are representative of three independent experiments.
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cell death similar to other pyroptosis inducers such as mono-
sodium urate (MSU), nigericin, or transfected poly(dA:dT) (Fig.
2E). Altogether these data suggest that treatment with NFR ac-
tivates an inflammasome.
Nelfinavir Triggers the Formation of an ASC-Dependent Inflammasome.
The adaptor protein ASC is a major constituent of virtually all
pyrin domain (PYD)-containing inflammasomes. Upon activa-
tion, ASC polymerizes and assembles into large ASC specks (26,
27). These aggregates can be detected biochemically by moni-
toring the precipitation of ASC in insoluble fractions and at the
cellular level by confocal microscopy. Both approaches revealed
endogenous ASC specks formation upon treatment of macro-
phages with NFR (Fig. 3 A and B). To quantify inflammasome
formation, we developed a protocol to detect ASC specks by
imaging flow cytometry (Fig. 3C, Left). By gating on morpho-
logically intact cells, we could quantitatively detect an inflam-
masome ASC speck in ∼1.5% of NFR-treated cells and in 5% of
cells transfected with poly(dA:dT) (Fig. 3C, Right). In both cases
the measured enrichment was statistically significant, indicating
that after a 6-h treatment a relatively small but significant
number of live cells have visible inflammasome specks.
To demonstrate that ASC is essential for NFR-mediated
inflammasome, we stably transfected THP-1 cells with a construct
expressing a shRNA targeting human ASC. In this population
IL-1β maturation was decreased compared with cells expressing
a control shRNA (Fig. 3D). Similarly, ASC deficiency abolished
NFR-mediated inflammasome activity in mouse BMDMs (Fig.
3E and Fig. S2). Thus, the inflammasome activity observed upon
treatment with NFR likely relies on a PYD-containing immune
sensor.
NFR-Mediated Inflammasome Activation Is NLRP3-Independent. The
NLRP3 inflammasome is a well-known sensor of cellular dam-
age, ER stress, and metabolic stress (12, 28). However, com-
pared with drugs that affect translation rates and trigger ER and
integrated stress responses, we found that NFR is a more potent
and rapid inducer of IL-1β maturation (Fig. S3A). In line with
these observations, NFR did not affect mitochondrial membrane
potential, in contrast to NLRP3 activators and carbonyl cyanide
m-chlorophenyl hydrazone (CCCP), a chemical inhibitor of ox-
idative phosphorylation (Fig. S3B). Moreover, NFR-mediated
inflammasome activation was not significantly affected by
NLRP3 deficiency (Fig. 4A). Inhibitors of NLRP3 activation,
including the addition of extracellular potassium or antioxidants
(29, 30), blocked inflammasome activity triggered by the NLRP3
activator nigericin, but did not affect NFR- or poly(dA:dT)-
mediated caspase-1 activation (Fig. 4B). These findings indicate
that NFR-mediated inflammasome assembly does not rely on
typical NLRP3-activating pathways and may therefore define
new mechanisms of inflammasome activation.
Nelfinavir Disrupts the Nuclear Envelope Integrity. The HIV-pro-
tease inhibitors were designed to target the active site of the
HIV-protease. The observation that all of the inhibitors (except
Amprenavir) activate the inflammasome (Fig. S1A) led us to
hypothesize that these molecules may target a cellular protease.
We used quantitative proteomics to search for putative cellular
substrates, the processing of which could be impaired in the
presence of NFR (31). To avoid cell death, we performed the
experiment in HeLa as a model cell line that is not competent for
inflammasome formation and subsequent pyroptosis. Cells treated
with NFR or vehicle were analyzed by stable isotopic labeling with
amino acids in cell culture (SILAC) coupled with protein molecular
weight (MW) separation and mass spectrometry (Fig. 5A). This
approach identified proteins displaying changes in electrophoretic
mobility induced by NFR. Among the 19 putative candidates
identified to have a pattern compatible with reduced processing,
lamin A was selected as a promising target (Fig. S4). Lamin A is a
component of the nuclear lamina, a scaffold structure underlying
the inner nuclear membrane (32). The posttranslational maturation
of lamin A is a highly regulated pathway that includes the pro-
teolytic conversion of farnesylprelamin A to lamin A, a process that
depends on the protease Zmpste24 (33). Zmpste24 deficiency and
other mutations impairing the maturation of prelamin A to mature
lamin A cause progeroid syndromes that include lipodystrophy as a
typical feature (34). Similarly, treatments with HIV-PIs including
NFR trigger lipodystrophy and metabolic deregulations in patients,
which resemble syndromes caused by missense mutations in lamin
A (35). The similarities between these symptoms has led to the
observation that long-term treatments with some of the HIV-PIs,
including Lopinavir, inhibit Zmpste24 activity and lamin A matu-
ration (36), a finding that was not validated in peripheral blood
mononuclear cells (37). In contrast, adipocytes differentiating in the
presence of Indinavir or NFR showed altered lamin A maturation
(38). In line with these observations, we found that, similar to the
inhibitor of protein geranylgeranyltransferase (GGTI) that is a de-
scribed antagonist of Zmpste24 (39), treatments with NFR triggered
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Fig. 4. Inflammasome activation is NLRP3-independent. (A) Immunoblot
analysis of caspase-1 and IL-1β maturation in NLRP3-deficient and control
(WT) BMDMs primed with LPS as indicated and treated with NG for 30 min or
with Lipo, poly(dA:dT), and NFR for 6 h. SN: supernatant; XT: cell extracts.
Data are representative of at least three independent experiments. (B) LPS-
primed iBMDMs were treated with Lipo, poly(dA:dT), or NFR for 6 h. These
experiments were done in the absence or presence of 50 μM KCl or 20 μM of
N-acetyl-cysteine (NAC). Caspase-1 activation and expression were measured
by immunoblot of supernatant (SN) or cell extracts (XT), respectively. Data
are representative of at least three independent experiments.
E4674 | www.pnas.org/cgi/doi/10.1073/pnas.1602419113 Di Micco et al.
the accumulation of prelamin A (Fig. 5B). Increased prelamin A
accumulation was observed as early as 3 h after treatment with NFR
(Fig. 5C), confirming that this molecule is a rapid and efficient
inhibitor of lamin A maturation. We performed a cycloheximide
chase after GGTI washout. In this experiment GGTI washout re-
stored the maturation of prelamin A in absence of de novo protein
synthesis. When the washout was performed in presence of NFR,
maturation of prelamin A was delayed and some prelamin A was
detected 4 h after washout (Fig. S5A). These findings are consis-
tent with previous reports (36, 38) and suggest that NFR may
affect prelamin A maturation by inhibiting Zmpste24. Zmpste24
enzymatic activity can be measured with an endoprotease-coupled
methylation assay using a synthetic farnesylated a-factor peptide
substrate (40). In this assay, Zmpste24 cleaves the substrate, ren-
dering it available for methylation isoprenylcysteine carboxyl
methyltransferase. By measuring substrate methylation to quantify
Zmpste24 activity, we found that NFR inhibited Zmpste24 in a
dose-dependent manner (Fig. 5D) similarly to GGTI, ritonavir,
and lopinavir (Fig. S5B). In contrast, Amprenavir did not inhibit
Zmpste24 activity (Fig. S5B). Taken together, these data dem-
onstrate that NFR can rapidly affect lamin A maturation to pro-
mote accumulation of prelamin A in cells.
As structural components, nuclear lamins provide morpho-
logical and mechanical stability to the nucleus. Defects in lamin
A maturation have been associated with significant changes in
nuclear shape (41). Consistently, NFR and GGTI were found to
affect nuclear morphology both in BMDMs (Fig. 5E) and HeLa
cells (Fig. S6A). This was quantified by imaging flow cytometry,
confirming that NFR significantly increased the number of cells
harboring a misshapen nucleus (Fig. 5F and Fig. S6B). This ef-
fect was not inhibited by the caspase inhibitor zVAD-fmk, in-
dicating that alteration of nuclear shape was not a result of
inflammasome-mediated caspase activation (Fig. S6C).
Nelfinavir Triggers the Release of Nuclear DNA.Mutations affecting
lamin A maturation have been shown to cause nuclear envelope
stress characterized by intermittent, nonlethal ruptures of the
nuclear envelope, which can lead to temporary exchange of
components between the nuclear and cytoplasmic compartments
(42). Consistent with these observations, we found that treat-
ment with NFR triggered the detection of DNA in the cytosol
(Fig. 6A and Fig. S6D). We used imaging flow cytometry to
quantify NFR-mediated DNA release. The analysis confirmed
that NFR induced a significant DNA release in the cytosol (Fig.
6B). This DNA release was not accompanied with increased
phosphorylation of γH2AX or CHK1, indicating that NFR does
not promote significant DNA damage (Fig. S7).
Given that the innate immune system samples the presence of
double-stranded DNA in the cytosol as a marker of viral and
bacterial infections, it is therefore conceivable that the release of
self-DNA could engage innate immune sensors. For example,
the protein cyclic GMP-AMP synthase (cGAS)-stimulator of
interferon genes (STING) pathway detects the presence of cytosolic
DNA and, in response, triggers expression of inflammatory medi-
ators related to the type I IFN response (43). Treatment with NFR
for 15 h triggered the expression of typical type I IFN-responsive
genes such as Cxcl10 and Isg15 in cGAS-proficient BMDMs but not
in cGAS-deficient BMDMs (Fig. 6C). Similarly, NFR-mediated
induction of Ifnβ, Cxcl10, and Isg15 was cGAS-dependent in mouse
embryonic fibroblasts (MEFs) (Fig. S8A). We performed genome
editing by means of CRISPR/Cas9 to inactivate the STING gene
in HeLa cells and confirmed that STING is required for NFR-
mediated induction of Isg15 in HeLa cells (Fig. S8B). Moreover,
inactivation of Zmpste24 by CRISPR/Cas9 in HeLa cells triggered
basal increase in Isg15 (Fig. S8C). These observations indicate that
perturbation of lamin A maturation with NFR or by altering
Zmpste24 expression activates the DNA-sensing pathway cGAS-
STING and support the finding that DNA is detected in the cy-
tosol of NFR-treated cells.
In line with these observations, we found that overexpression
of the cytosolic DNase TREX1 decreased inflammasome
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Fig. 5. Nelfinavir impairs lamin-A maturation. (A) Quantitative proteomics
using SILAC. Two populations of HeLa cells were fully labeled with either
normal (light) or heavy isotopes and treated with NFR or vehicle, respectively,
for 6 h. After lysis and protein quantitation, the two samples were mixed at a
1:1 ratio, followed by gradient SDS/PAGE and cutting of the gel into 48 slices.
Each gel slice was then submitted to trypsin digestion and LC-MS/MS and
relative quantitation of proteins in each slice. The profiles along the gel are
then reconstructed for each protein together with their abundance and heavy-
over-light (H/L) ratios. Proteins with lower apparent molecular weight bands
reduced and higher apparent molecular weight increased in the presence of
NFR were considered candidate protease substrates affected by NFR. m/z,
mass-to-charge ratio. (B and C) HeLa cells were treated with increasing doses
of NFR or the Zmpste24 inhibitor GGTI for 6 h (B) or with 10 μM of NFR for the
indicated times (C). Cell lysates were analyzed for prelamin A accumulation by
immunoblotting. Tubulin (Tbl) was used as a loading control. Data are rep-
resentative of at least three independent experiments. Asterisk indicates a
nonspecific signal. (D) Inhibition of ZMPSTE24 by NFR as measured by the
endoprotease-coupled methylation assay described inMaterials and Methods.
The assay was performed on membrane preparations from Δste24Δrce1 yeast
expressing human ZMPSTE24 using a synthetic farnesylated a-factor peptide as
the substrate. The results are presented as percentage of the specific activity
measured in presence of vehicle. Data are representative of three independent
experiments. (E) Immunofluorescence microscopy of BMDMs treated 6 h with
NFR or the Zmpste24 inhibitor GGTI as indicated. DNA staining is shown in blue
(Hoechst); lamin B staining is shown in green. Representative images with
misshapen nuclei are shown. (Scale bar: 10 μm.) (F) ImageStream flow cyto-
metric analysis of nuclear shapes. Quantification of misshapen nuclei detected
in BMDMs treated for 6 h with NFR or vehicle (Mock). Data are means ± SEM
from three independent experiments analyzing at least 20,000 cells. *P < 0.05.
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activation by NFR (Fig. 6D) but not by the NLRP3 activator
Nigericin (Fig. S9), indicating that cytosolic release of DNA may
act as a stress signal that promotes inflammasome assembly.
The AIM2 Inflammasome Is a Sensor of Cytosolic Self-DNA. Cyto-
plasmic transfection of poly(dA:dT), microbial, or host DNA has
been shown to activate the AIM2 inflammasome (7–10). Re-
ducing AIM2 expression by shRNA in THP-1 cells decreased
NFR-mediated IL-1β secretion, similar to the phenotype ob-
served with the known AIM2 activator poly(dA:dT) (Fig. 7A).
Likewise, AIM2-deficient BMDM and iBMDM clones impaired
IL-1β secretion in the presence of NFR (Fig. 7 B and C). NFR-
mediated caspase-1 processing was also impaired by AIM2 de-
ficiency whereas MSU and nigericin response was unaffected
(Fig. 7D). ASC oligomerization was also impaired in the absence
of AIM2 (Fig. 7E), indicating that AIM2 is required for
inflammasome assembly. Moreover, reconstitution of AIM2-
deficient iBMDM with a construct expressing AIM2 restored
poly(dA:dT) and NFR-mediated inflammasome activation (Fig.
7F), further demonstrating that AIM2 is key in sensing NFR-
mediated stress response.
Treatment with the Zmpste24 inhibitor GGTI triggered prel-
amin A accumulation leading to nuclear envelope defects and
misshapen nuclei (39). We therefore tested whether this mole-
cule activates an AIM2 inflammasome. Similarly to NFR, we
found that GGTI triggered an IL-1β secretion that is affected by
AIM2 deficiency (Fig. 7G). AIM2 is therefore a key nuclear
envelope integrity sensor that detects the release of self-DNA
into the cytosol.
Discussion
The inflammasome was initially described as an ASC- and cas-
pase-1–containing complex that spontaneously assembles in
THP-1 cell extracts following disruption of cellular integrity us-
ing mechanical cell lysis in a hypotonic buffer (3). This led to the
notion that, analogous to a model proposed in the field of plant
immunity (44), some mammalian innate immune receptors may
function as guardians of cellular integrity. Although NLRP3 has
been described as a sensor of various cellular stresses, the de-
tailed mechanisms of its activation are still a matter of debate,
and very few intrinsic danger signals have been described.
Here we present several lines of evidence indicating that self-
DNA can function as a relevant intrinsic signal leading to AIM2-
dependent inflammasome activation: First, we demonstrate that
NFR triggers the release of IL-1β independently of the NLRP3
inflammasome. Second, we show that treatments with NFR re-
produce a nuclear envelope stress response that causes the ex-
posure of self-DNA in the cytosol. Third, we found that expression
of the cytosolic DNA exonuclease TREX1 impairs inflammasome
activation. And finally, we identified AIM2 as the inflammasome
sensor that mediates IL-1β release upon treatment with the
Zmpste24 inhibitor GGTI or NFR.
In transfection experiments AIM2 has been shown to detect
dsDNA in a sequence-independent manner and from virtually
any pathogen and species tested, including mammalian DNA
(45–47). Evidence that AIM2 can recognize mammalian DNA is
also supported by studies in inflammatory models. AIM2-
dependent release of IL-1β in the skin has been shown to con-
tribute to the pathogenesis of psoriasis (48). In this disease,
scavenging of DNA by the antimicrobial cathelicidin peptide LL-
37 reduced IL-1β secretion, suggesting that extracellular DNA
(possibly of self-origin) could act as a danger signal. Similarly, in
arthritis models driven by deficiency of the lysosomal endonu-
clease DNase2, the impaired ability of macrophages to degrade
self-DNA released by damaged tissues triggers an inflammatory
syndrome that is partially AIM2-dependent (49, 50).
Although these previous reports clearly suggest that self-DNA
is a danger signal that can be released by dying cells (51), the
notion that transient DNA exposure by stressed nuclear enve-
lope structures can signal AIM2 activation is an intriguing notion
that could have implications under different physiological and
pathological conditions. Inside the body, cells are continuously
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Fig. 6. Nelfinavir promotes the release of nuclear DNA. (A) Immunofluo-
rescence microscopy of BMDMs treated for 6 h with NFR. Staining for dsDNA
(red) and lamin B (green) is shown. Representative images with cytosolic
dsDNA are shown. (Scale bar: 10 μm.) (B) ImageStream flow cytometric
analysis of cytosolic DNA content. (Upper) Representative images of extra
nuclear DNA detected in the cytosol of BMDMs treated for 6 h with NFR.
(Lower) Quantification of cells with cytosolic DNA. Data are means ± SEM
from three independent experiments analyzing at least 20,000 cells. *P <
0.05. (C) Relative mRNA levels measured by RT-qPCR of Cxcl10 and Isg15 in
cGas+/+ and cGas−/− BMDMs stimulated for 15 h with 25 μM NFR or 500 ng/mL
LPS. (D) iBMDMs stably overexpressing a Flag-tagged version of TREX1 or
control population were primed with LPS as indicated and treated with Lipo,
poly(dA:dT), and NFR. Caspase-1 and IL-1β maturation were analyzed by im-
munoblotting. Tubulin (Tbl) is used as a loading control. SN: supernatant; XT:
cell extracts. Data are representative of two independent experiments.
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exposed to physical forces and mechanical constraints of their
microenvironment that can perturb membrane integrity. Onco-
genic programs, infections, inherited mutations, and chemicals
can increase these stresses and affect the ability of cells to cope
with them (52, 53). For example, infection with HIV can cause
dramatic nuclear envelope instability accompanied by prominent
lamina gaps as well as large blebs of herniating chromatin resulting
in the mixing of nuclear and cytoplasmic components (54). Because
the human AIM2-like protein IFI16 was found to be activated by
the cytosolic accumulation of incomplete HIV reverse transcripts
to promote pyroptosis of lymphoid CD4 T cells (55), it would be
interesting to interrogate the contribution of HIV-mediated nu-
clear envelope stress to pyroptosis. Inflammasome activation has
also been detected in rhesus monkeys following mucosal simian
immunodeficiency virus infection, both at the site of inoculation
and at sites of distal virus spread (56), suggesting that this innate
immune pathway may contribute to early defense against retro-
viruses. The fact that NFR can promote inflammasome activation
raises the question of whether this drug may synergize with HIV to
alter the course of infection in treated patients. Other innate im-
mune sensors of cytosolic DNA engaged by treatment with NFR
may also contribute to immunity against HIV, including cGAS, a
pathway that has been shown to detect and drive inflammatory
mediators upon infection with HIV (57).
Transient nuclear rupture has been observed in cultured
laminopathy patient fibroblasts (42). Consistently, discontinuities
of the nuclear envelope are visible by electron microscopy in
hearts of mutant mice deleted for lysine 32 of lamin A (58) and
in the liver of lamin A-deficient animals (59). Furthermore, in a
mouse model of laminopathy caused by Zmpste24, an inflammatory
phenotype was shown to contribute to aging (60). It is therefore
tempting to speculate that the inflammasome could contribute to
increased aging observed in laminopathies. Both pyroptosis and
IL-1 secretion could contribute to chronic sterile parainflammation
that characterizes aging in these diseases (61). Among the hall-
marks of both laminopathies and treatments with the HIV-PIs,
partial lipodystrophy is particularly remarkable (35). It is therefore
likely that AIM2 activation in combination with other effects of
nuclear membrane stress may contribute to these metabolic alter-
ations (34).
Cancer cells also often exhibit changes in lamin A expression
and nuclear morphology that resemble the phenotype observed
in laminopathies, indicating that cancer cells may experience
transient nuclear envelope rupturing (62, 63). This was shown
experimentally; cancer cells forced to squeeze through tiny pores
undergo repeated rupturing and repair of the nuclear envelope
(64, 65), further indicating that the nuclear stress response is
relevant to migrating cells, possibly contributing to metastasis.
Interestingly, AIM2 expression is deregulated in various tumors,
B C
E F
D
G
A
Fig. 7. The DNA-sensor AIM2 mediates NFR and GGTI-driven inflammasome activation. (A) Human THP-1 macrophages expressing a scrambled shRNA
(shScrbl) or two independent shRNA directed against AIM2 (shAIM2) were differentiated and primed with PMA (0.5 μM) and treated with poly(dA:dT) or NFR
for 6 h as indicated. IL-1β release was measured by ELISA. (B) LPS-primed BMDMs isolated from AIM2-deficient animals (AIM2−/−) or controls (WT) were treated
with 20 μM NFR. IL-1β release was measured by ELISA. (C) WT iBMDMs and three clones isolated from AIM2-deficient animals (clones B, C, and H) were primed
with LPS and treated with Lipo, poly(dA:dT), or 20 μM NFR for 6 h as indicated. IL-1β release was measured by ELISA. (D) Immunoblot analysis of caspase-1 and
IL-1β maturation in AIM2-deficient and control (WT) BMDMs primed with LPS as indicated and treated with NG, MSU, Lipo, poly(dA:dT), and NFR. SN:
supernatants; XT: cell extracts. Tubulin (Tbl) is used as a loading control. (E) iBMDMs from WT or AIM2-deficient mice were primed with LPS and treated with
20 μMNFR. Cross-linked pellets (Pell) or soluble lysates (Lys) were immunoblotted for ASC. (F) Immunoblot analysis of caspase-1 and IL-1βmaturation in AIM2-
deficient iBMDMs reconstituted with an inducible Flag-tagged AIM2 protein and control (WT) primed with LPS as indicated and treated with NG, Lipo, poly
(dA:dT), or NFR. Doxycycline (Dox) was used to induce the AIM2 expression. SN: supernatants; XT: cell extracts. Tbl was used as a loading control. (G) LPS-
primed iBMDMs from AIM2-deficient animals (AIM2−/−) or controls (WT) were treated with 10 μM of the Zmpste24 inhibitor GGTI, and IL-1β release was
measured by ELISA. Data in A–G are representative of at least three independent experiments.
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and experiments in mice have shown that it has tumor suppressor
properties; however, these effects may not rely on the assembly
of a caspase-1–activating inflammasome (47, 66, 67). Whether
nuclear rupture in cancer cells activates AIM2 to trigger pyrop-
tosis and/or tumor immunogenicity is a tempting hypothesis that
needs to be addressed. This hypothesis would be consistent with
the observation that the ASC adaptor is down-regulated in many
tumor types (68). Furthermore, in tumors expressing AIM2 and
the other inflammasome components, NFR may synergize with
preexisting nuclear envelope stress, possibly exacerbating cytosolic
self-DNA exposure. This may contribute to the well-described
NFR antitumoral properties (20).
The discovery that self-DNA can activate endogenous immune
pathways raises an additional question that remains to be addressed.
For example, it is unclear how AIM2 activation is prevented
during mitosis. One possibility is that AIM2 is regulated by mitotic
factors as reported for NLRP3 (69, 70). We previously showed
that treatment with HIV-PIs triggers a transcriptional and trans-
lational reprogramming via the integrated stress response. Whether
this pathway could contribute to nuclear envelope repair, similar to
its role during endoplasmic reticulum stress response, is an open
question that remains to be investigated.
In summary, our results identify AIM2 as a guardian of nuclear
envelope integrity beyond its well-described role as a pathogen
sensor and suggest that it may have regulatory functions in
stressed tissues.
Materials and Methods
Cell culture, ELISA, chemicals and antibodies, generation of shRNA clones,
generation of CRISPR/Cas9 clones, RNA extraction and RT-PCR of IFN-responsive
genes, membrane potential measurement, and Slice-SILAC protein and MS
analysis are described in SI Materials and Methods.
Isolation of BMDMs. Murine BMDMs were generated by crushing the femur
and tibia bones frommice using a sterile mortar and pestle in 5 mL of DMEM,
2% (vol/vol) FBS, and 1% penicillin/streptomycin (P/S), and fluid was filtered
with a nylon cell strainer. Cells were spun at 1,500 × g for 10 min at 4 °C and
plated in a 10-cm nonadherent petri dish. After 5 d the adherent cells were
detached with 3 mL of accutase for 5 min and centrifuged at 1,500 × g for
5 min. The cell pellet was resuspended and cultured in F12 medium (GIBCO),
20% (vol/vol) conditioned media from L929 cells, 10% (vol/vol) FBS, and 1% P/S.
Inflammasome Activation. Before stimulation, THP1 cells were differentiated
for 3 h in the presence of 0.5 mM phorbol 12-myristate 13-acetate (PMA) (71).
Cells were washed twice with PBS, plated onto 12-well plates, and left to
adhere overnight. The following day, the culture medium was removed and
replaced with fresh media before stimulation as indicated. BMDMs were
plated in a 12-well plate overnight. The following day media were changed
before stimulation with OPTIMEM (GIBCO) for the Western blot analysis or
with complete RPMI media for the ELISA analysis. Cells were stimulated with
5 μM of nigericin (NG) for 30 min; 5 mM of ATP for 1 h; and 10, 20, and 50 μM
of NFR for 6 h or 2 μg of poly(dA:dT) was transfected for 3–4 h. After
stimulation supernatant was collected and proteins were precipitated by the
methanol/chloroform method.
Mice. Caspase-1−/−, AIM2−/−, NLRP3−/−, ASC−/−, and cGAS−/− mice on a C57BL/
6J background were previously described (24, 72, 73). Mice were bred in the
Center of Infection and Immunity animal facility at the University of Lau-
sanne or at the Plateau De Biologie Expérimentale De La Souris (Lyon,
France). All animal experiments were approved by the Veterinary Office of
the Canton de Vaud and the Animal Ethics Committee (authorization 2390)
and were performed according to local guidelines.
Peritonitis Model. Peritonitis was induced in 7- to 12-wk-old age- and sex-
matched mice by i.p. injection of 100 mg/kg of NFR. NFR was dissolved in
delivery vehicle containing 10% (vol/vol) DMSO, 5% (vol/vol) PEG, and 5%
(vol/vol) Tween 80. After 5 h the peritoneal cavity was flushedwith sterile PBS.
The lavage fluid was centrifuged, and the pelleted cells were counted and
analyzed for the influx of neutrophils (CD11b+, LY6C+, LY6G+) by flow
cytometry. Data were collected with a DB Accuri C6 flow cytometer (BD
Biosciences) and analyzed with FLOWJO software.
Lactate Dehydrogenase Release Assay. Lactate dehydrogenase (LDH) is rapidly
released into the cell-culture supernatant upon damage of the plasma
membrane. The release of LDHwas detected using the Cytotoxicity Detection
kit from Roche. The kit was used according to the manufacturer’s instruction.
Reconstitution of AIM2 KO Cells and Generation of TREX1-Overexpressing Cells.
Lentiviral pINDUCER21 plasmid was obtained from Steve Elledge, Harvard
Medical School, Boston (74). A human Flag-tagged AIM2 or TREX1 construct
were cloned into the pENTR 1A dual selection vector (Invitrogen) and then
cloned in the pINDUCER21, a GFP tet-inducible lentiviral vector plasmid.
Lentiviruses were produced as previously described (75). AIM2−/− iBMDMs
were infected with AIM2-expressing lentiviruses, and iBMDM were infected
with TREX1-expressing lentiviruses. GFP-positive cells were FACS-sorted 96 h
postinfection. Cells were cultured in complete medium, and Flag-tagged
AIM2 or TREX1 expression was induced using doxycycline (1 μg/mL for 24 h).
ASC Oligomerization Assay. iBMDMs were primed with 100 ng of LPS for 3 h
and then treated with 20 μM NFR for 6 h and 5 μM NG for 30 min or trans-
fected with 2 μg/mL poly(dA:dT) for 3–4 h. After stimulation the supernatant
was kept to test IL-1β release and caspase-1 cleavage by Western blot. Cells
were detached with PBS containing 2 mM EDTA and centrifuged 5 min at
1,500 × g. Cells were lysed on ice in 500 μL of Buffer A (20 mM Hepes·KOH,
pH 7.5, 10 mM KCl, 1.5 mMMgCl2, 1 mM EDTA, 1 mM EGTA, 320 mM sucrose)
by syringing 30 times using a 21-G needle. The cell lysates were centrifuged in
1.5-mL Eppendorf tubes at 1,800 × g for 8 min to remove the bulk nuclei, and
30 μL of the supernatants were kept for Western blot analysis to test ASC
expression in the lysates. The remaining supernatant was diluted two times
with Buffer A and centrifuged 5 min at 2,000 × g. After centrifugation, su-
pernatant was diluted with 1 vol of CHAPS buffer (20 mM Hepes·KOH, pH 7.5,
5 mM MgCl2, 0.5 mM EGTA, 0.1 mM PMSF, 0.1% CHAPS) and again centri-
fuged at 5,000 × g for 8 min to pellet the ASC pyroptosome. The supernatant
was discarded and the pellet was resuspended in 50 μL of CHAPS buffer with
4 mM of disuccinimidyl suberate (Thermo Scientific) for 30 min at room tem-
perature (RT). Samples were centrifuged at 5,000 × g for 8 min, and pellets
were resuspended in 30 μL of 2× loading buffer in nonreducing conditions for
Western blot.
Endoprotease-Coupled Methylation Assays. The assays were performed as
previously described with minor modifications (36, 39, 76). Reactions contained
5 μg of membranes from ste24Δ rce1Δ yeast expressing human ZMPSTE24, 10 μg
of membranes expressing yeast isoprenylcysteine carboxyl methyltransferase
Ste14p (77), 15 μM farnesylated a-factor peptide [YIIKGVFWDPA-(Fr)CVIA] (EZ
Biolabs), and 20 μM S-adenosyl [14C-methyl]-L-methionine (55 mCi/mmol) (Per-
kin-Elmer) in 100 mM Tris·HCl, pH 7.5, in a final volume of 60 μL. The reactions
also contained HIV-PIs at the indicated concentration. After incubating the re-
actions at 30 °C for 30 min, the reactions were stopped with 50 μL of 1 M NaOH/
1% SDS and then spotted on pleated filter paper. Each filter paper was lodged
into the neck of a vial containing 10 mL of scintillation fluid (RPI), capped, and
allowed to diffuse at room temperature for 3 h. The base-releasable [14C]-
methanol was quantified by liquid scintillation counting. Background counts
from ste24Δ rce1Δ yeast with empty vector (77) were subtracted from each
sample. IC50 determinations were performed in triplicate and calculated by using
GraphPad 4.0.
Immunofluorescence Staining for Image Stream Analysis. iBMDMs were
seeded the day before the experiment in six-well plates and then stimulated
for 4–6 h with the indicated concentrations of Nelfinavir, lipofectamine, or
lipofectamine and 1 μg/mL poly(dA:dT) in the presence of 1 μg/mL LPS. Cells
were detached and washed once with PBS containing 2 mM EDTA before
fixation in fixation/permeabilization buffer [PBS, 2% (vol/vol) PFA, 0.3%
Triton X-100] for 15 min at 4 °C. After two washes in FACS buffer [PBS, 2%
(vol/vol) FCS, 0.3% Triton X-100, 2 mM EDTA], cells were incubated overnight
at 4 °C with primary antibodies against ASC, dsDNA, and lamin B1 diluted
1:300 in FACS buffer. Cells were washed twice in FACS buffer and incubated
for 1 h with secondary antibodies diluted 1:500 in FACS buffer at RT. Heochst
was added at a final concentration of 10 μg/mL for the last 5 min of incubation
with secondary antibodies. After a final wash, cells were resuspended in 50 μL
of FACS buffer and analyzed with the Image Stream.
Image Stream Analysis. Cells were acquired using Inspire software on a 4-laser
12-channel imaging flow cytometer Image StreamX MarkII (Millipore) using
40× magnification. At least 10,000 single cells were acquired per sample,
with debris and doublets excluded based on their area and aspect ratio. For
analysis, cells in focus (using the “gradient RMS” feature for the brightfield
image) and single cells (in a plot using “area” versus “aspect ratio”) were
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gated. Based on the intensity, cells positively stained for lamin B, dsDNA, and
ASC were selected, whereas cells with a sub-G0 DNA (based on Hoechst in-
tensity) content were excluded. In addition, using a Hoechst threshold mask
of 50% combined with the spot count feature, cells with fragmented nuclei
that were presumable dead were excluded.
To assess the circularity of the nucleus, the circularity feature was calcu-
lated using morphology masks of lamin B and Hoechst, respectively. Cells
showing circularity values higher than 10 for both features were considered
to have round nuclei.
To analyze ASC speck formation, the area of the ASC signal was plotted
against the Max pixel value of ASC. Signals with a small area and a high
maximum pixel value were considered to be ASC specks. For analysis of
dsDNA in the cytoplasm, a threshold mask of 80% for the dsDNA signal was
calculated, which allowed to distinguish small dsDNA dots in the nucleus
from the nucleus itself. Using the spot count feature on the dsDNA threshold
mask, cells showing two or more dsDNA spots were considered to have
dsDNA in the cytoplasm.
Immunofluorescence Staining for Confocal Microscopy. For confocal micros-
copy HeLa cells or iBMDMs were plated the day before the experiment on
15-mm coverslips in 12-well plates. After treatment the cells were fixed with
2% (vol/vol) PFA (Applichem) for 20 min at RT. The cells were then per-
meabilized with 0.1% Triton X-100 in PBS for 10 min and washed once with
PBS. The aspecific sites were blocked with 3% (wt/vol) BSA prepared in PBS
for 30 min at RT. The antibodies against lamin B, dsDNA, and ASC were
diluted 1:500 in 1% BSA and incubated on the coverslips overnight at 4 °C.
The next day the cells were washed five times with PBS, and the fluorescent
secondary antibodies [anti-IgG(H+L) Alexa Fluor conjugates, Thermo Scientific]
diluted 1:1,000 in 1% BSA were applied for 1 h. The coverslips were washed
again with PBS and incubated 5 min with the Hoechst dye diluted in PBS at the
final concentration of 4 μg/mL. The coverslips were mounted on slides using
ProLong Gold Antifade (Invitrogen). Images were captured using an inverted
confocal microscope LSM 510 META (Zeiss) equipped with a 63×/1,40 oil-
immersion objective, processed with Zeiss Axiovision software, and analyzed
with ImageJ across at least 10 fields from three independent experiments.
Statistical Analysis. All data are representative of at least three different
experiments. Data are mean ± SEM of three independent experiments. For
ImageStream analysis data comparing mock with NFR- or poly(dA:dT)-
treated cells, P values were calculated using the two-sided Student t test,
and three independent experiments with at least 20,000 cells per experi-
ments were analyzed. For in vivo experiments, P values were calculated us-
ing the two-sided Student t test comparing NFR with vehicle.
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